Balanced translocations affecting the llq23 region are among the most frequent chromosomal abnormalities in childhood acute lymphoblastic leukemia (ALL), comprising 5% to 6%. These cases consistently have a rearranged MLL gene and are associated with high-risk presenting features, hyperleukocytosis and younger age, and a poor treatment outcome. To assess the clinical and biologic significance of 1 lq23-associated structural chromosomal abnormalities other than translocations, we studied 17 cases of childhood ALL [ l 4 with del(ll)(q23) and 3 with inv(ll)(p12q23)1 that were identified among 785 cases with successful chromosome analysis. In contrast to reported cases with 1 lq23 and HROMOSOME BAND 1 lq23, the location of the MLL gene, is a region of recurrent translocations in human malignancies. The usual consequence of llq23 translocations is the fusion of N-terminal sequences of the MLL gene to a variety of partners producing chimeric products with putative transforming activities."' Cases of childhood acute lymphoblastic leukemia (ALL) with rearrangements of this gene are generally characterized by a young age, high white blood cell counts, organomegaly, central nervous system (CNS) involvement, a B-precursor cell immunophenotype without CDlO expression but with coexpression of the myeloid associated antigens CD15 and CDw65, and a poor Such cases largely account for the dismal prognosis ascribed to infants with Molecular studies of the cases with llq23 chromosomal translocation have consistently shown involvement of the MLL gene2".9"0*12"7 and application of these molecular approaches has identified additional cases that were missed or not appreciated by cyto-1 lq23 regions by mechanisms other than balanced translocations similarly affect MLL is unknown. We describe here findings in 17 consecutive cases with either a deletion or inversion affecting the q23 band on chromosome 11.
HROMOSOME BAND 1 lq23, the location of the MLL gene, is a region of recurrent translocations in human malignancies. The usual consequence of llq23 translocations is the fusion of N-terminal sequences of the MLL gene to a variety of partners producing chimeric products with putative transforming activities."' Cases of childhood acute lymphoblastic leukemia (ALL) with rearrangements of this gene are generally characterized by a young age, high white blood cell counts, organomegaly, central nervous system (CNS) involvement, a B-precursor cell immunophenotype without CDlO expression but with coexpression of the myeloid associated antigens CD15 and CDw65, and a poor Such cases largely account for the dismal prognosis ascribed to infants with Molecular studies of the cases with llq23 chromosomal translocation have consistently shown involvement of the MLL gene2".9"0*12"7 and application of these molecular approaches has identified additional cases that were missed or not appreciated by cyto-1 lq23 regions by mechanisms other than balanced translocations similarly affect MLL is unknown. We describe here findings in 17 consecutive cases with either a deletion or inversion affecting the q23 band on chromosome 11. C genetic ana~ys~s~9-lo.12-13.17-zl Whether rearrangements of the
MATERIALS AND METHODS

Patients.
From December 1979 to December 1993, 1,161 consecutive children with newly diagnosed ALL were admitted to St Jude Children's Research Hospital (SJCRH) and enrolled in one of four successive Total Therapy studies (X-XIII)."-24 The diagnosis of ALL was based on morphologic criteria of the French-AmericanBritish (FAB) Cooperative Group, including negative staining for myeloperoxidase and nonspecific e~terase.'~ We successfully analyzed the leukemic cell karyotypes in 785 cases, including 14 with a deletion of chromosome 11 at band q23 and 3 with an inversion of chromosome 11 with breaks at p13 and q23. These patients are the subjects of the present report. Informed consent was obtained from all patients or their guardians, and the investigations were approved by the institution's Clinical Trials Review Committee.
Cytogenetic evaluation. Bone marrow samples were prepared by a direct with or without short-term (24-hour) lmmunophenotyping studies. Leukemic cell surface antigens were detected by standard indirect immunofluorescence assays with monoclonal antibodies to lymphoid and myeloid-associated antigens. Blast cells were also tested for surface (sIg) and cytoplasmic (cIg) Ig as previously described?' Depending on reactivity patterns, cells were classified as T (CD7+, CDY, E-rosette'), B (sIg'), pre-B (CIS'), early pre-B (cIg-, sIg-, HLA-DR', CD19+, CDlO'), or Bprecursor (sIg-, CD19', DR', CDIO', but unknown cIg status)." Southern blot analysis. Genomic DNA was extracted from the bone marrow of leukemic patients at diagnosis. Aliquots (5 to 8 pg) of high molecular weight DNA were digested with BamHI, HindIII, and Sac1 restriction endonucleases, separated by electrophoresis in 0.8% agarose gels, and blotted onto nylon membranes. All blots were hybridized with a 32P-labeled probe (Oncor, Gaithersburg, MD) derived from 0.74-kb BamHI cDNA fragment of the M U gene: This MLL probe will detect the common breakpoints of MLL between exons 5 through l1 with BamHI digests and breaks between exons 2 and 16 approximately on Sac I digest band size (Fig l) . 4 The membranes were then sequentially probed with p98.40, 4.2E, and ps4 probe^.^.'^.^' These three probes will detect breaks between exons 2 and 18 in BamHI-and HindIII-digested DNA (Fig 1) . Membranes were stripped in sodium hydroxide between hybridizations with each probe. The 4.2E probe required the inclusion of 300 p@ mL total human placental DNA (Sigma Chemical CO, St Louis, MO) 
RESULTS
Of the 14 cases with a del( 1 l)(q23), the deletion was the only chromosomal abnormality in 7 (nos. 1 through 7); the remainder had additional changes (Table l) , including a t(9;22)(q34;qlI) in 2 and a 12p abnormality in 3. The modal number was 46 in all but 3 cases ( I with 45 and 2 with 47 chromosomes). In none of these 14 cases was there cytogenetic evidence of an llq23 translocation or an interstitial deletion. Although the variability in the breakpoint assignment within this region cannot be defined further with any degree of certainty, 2 cases (no. 3 and 8) might have a more proximal breakpoint at 1 1 q22-23.
The median age of the 8 boys and 6 girls with a del(1 l)(q23) was 7.5 years at diagnosis (range, 2.3 to 14.7 years). Initial leukocyte counts ranged from 1.2 to 85.7 X 109/L (median, 7.5 X 109/L). Of the 13 del(1 l)(q23) cases with complete immunophenotyping, 8 were classified as early pre-B, 2 as pre-B. and 3 as T-cell ALL. CD10 was expressed in all but 2 cases with T-cell ALL. One T-cell case (no. 7) was positive for CD15 and CDw65. Of the only 3 cases with an adverse event, 2 (no. 2 and 6) are still alive at 8.9 and 2.5 years, respectively. The patient (no. 8) with an induction failure died 6 months after the initiation of therapy. The remaining 11 cases have been in continuous complete remission for 9+ to 149+ months (median, 30+ months).
A novel pencentric inversion of chromosome 1 I at bands p13 and q23 was seen in 3 cases, all with a pseudodiploid karyotype ( Table 1 and Fig 2) , and was the only abnormality in 1 case. Two cases were classified as early pre-B and 1 as T-cell ALL. CD10 antigen was expressed in all 3 cases, and CD15 and CDw65 were expressed in the T-cell case. The infant with T-cell ALL had a hematologic relapse and has 
46,X,?der(Y)t(Y;?)(qlZ;?),del(ll)(q23), G
inv ( died, whereas the 2 other children remain in remission for 7+ and 102+ months.
DNA was available for Southern blot hybridization for 11 of 14 cases with del(l1) and 2 of 3 cases with inv(l1). All 13 cases lacked evidence of a rearranged MLL gene using the cDNA MLL probe with BamHI, HindIII, and Sac I digests (Fig 3) . To further exclude an MLL break outside of the region detected by the 0.74-kb MLL probe, membranes with BamHI-or HindIII-digested DNA were stripped and reprobed with 4.2E, p98.40, and ps4. Studies with these three probes likewise showed only germline M U bands. Slight differences in the amounts of loaded DNA for each patient sample precluded qualitative assessment of the number of MLL copies detected by Southern blot. Densitometric Southern blotting using other 2 copy genes as baseline controls was not performed to search for evidence of deletions of an MLL locus.
DISCUSSION
The clinical characteristics of the 14 patients with a del(1 l)(q23) and the 3 with an inv(1 l)(p13q23) differed from those of patients with 1 lq23 translocations. The leukemic cell burden was relatively small; only 4 cases had an initial leukocyte count greater than 50 X 109L and 1 each had CNS involvement or splenomegaly. Moreover, expression of the myeloid-associated CD15 and CDw65 antigens was limited to single cases with a deletion or inversion. Tcell ALL, which is unusual among cases with 1 lq23 translocation~:~ was diagnosed in 4 patients in our series. Perhaps more important was the extended event-free survival in these patients, in contrast to the exceedingly poor outcome in cases with 1 lq23 translocations and MLL Thus, structural abnormalities affecting the llq23 region do not appear to confer a poor prognosis unless there is molecular evidence of MLL rearrangement. Previous molecular studies of cases with a deletion or inversion of the 1 lq23 region have yielded discrepant results regarding breaks in an MLL locus. Rearrangements of MLL with BamHI digests and probes as used in our cases were reported in 2 infants with M4 and M5 AML and a del(1 l)(q23) and del(] l)(q21), re~pectively~~; in 2 cases of acute leukemia with an interstitial deletion of Ilq'; in an infant and a 5-year-old child with a del(1 1)(q23Y2; in an adult with secondary AML and a del( 1 1)(q23.3-q24)33; in an infant with ALL and del( 1 1)(q23)I3; and in a de novo ALL patient with a del(1 l)(q23)." By contrast, MLL rearrangements were not found in 3 leukemias and 17 lymphomas with other 1 lq23 abnormalities that included deletions and duplications of 1 lq23 in one study: 2 infants with an 1 lq23 cytogenetic alteration," 2 adults with therapy-related AML and a del(1 l)(q13q23) or del(1 1)(q14q23),35 and an inv( 1 l)(pl lq23) in a case of Philadelphia-positive chronic myelogenous leukemia.36 Although it is difficult to reconcile the apparent higher frequency of involvement of MLL in patients in the literature, in some instances these cases may represent undetected translocations. This was demonstrated by Yamamoto et a13' in a cell line with a del( 1 l)(q23) using conventional cytogenetic analysis, but determined to have an MLL-LTGZ9 transcript using reverse transcription-polymerase chain reaction. Likewise, Kobayashi et al?' using fluorescence in situ hybridization, have shown that 1 lq23 deletions are mostly caused by undetected translocations.
The molecular probes (MLL, p98.40, ps4, and 4.2E) used in this study are sufficient to detect all described breaks between exons 2 and 18 of MLL4.9s29*30 This study does not exclude the possibility of breaks proximal and distal to exons 2 and 18, respectively. It is also possible that the entire M U locus is lost or that a locus other than MLL is involved in the cases with chromosome 1 lq23 deletions. Similarly, genes other than MLL within band q23 may be rearranged in the cases with inversions of chromosome 1 1. Fluorescence in situ hybridization studies with probes to distal and proxi- mal regions of MLL will help in further delineating where the breaks are occumng in these cases.
Infants with ALL and rearrangements of MLL have a poor clinical outcome.9"0.12.13 The frequency of M L L gene involvement and its effect on prognosis in older children with 1 lq23 translocations or other 1 lq23 abnormalities is uncertain. Recent studies have suggested that such rearrangements occur not only in association with the common llq23 translocations but in other 1 lq23 anomalies as well.s*'3~29~3z~33 B y contrast, we found that childhood ALL with the deletion of 1 lq23 or a novel inversion (1 l)(p13q23) lacked MLL gene rearrangement. Furthermore, patients with B-lineage ALL and del(1 l)(q23) or inv(ll)(p13q23) with no molecular evidence of MLL gene rearrangements do not appear to share the unfavorable prognosis of 1 lq23 translocations that involve MLL.
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